![Michael J. Flaim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mr. Flaim joined CHL Medical Partners in 2005.
Prior to joining CHL Medical Partners, he was a Financial Analyst in the Healthcare Investment Banking Group of Thomas Weisel Partners, advising public and private companies on financings, mergers, acquisitions, and strategic transactions.
Prior to joining Thomas Weisel Partners, Mr. Flaim interned in the Life Sciences Group of Index Ventures, Geneva, Switzerland where he conducted financial analysis and due diligence for prospective investments in the biotechnology and specialty pharmaceutical industries.
Mr. Flaim received his B.A. with Honors in Economics from the University of Chicago in 2003.
Anciens postes connus de Michael J. Flaim
| Sociétés | Poste | Fin |
|---|---|---|
CHL Healthcare Partners LLC
 CHL Healthcare Partners LLC Investment ManagersFinance CHL Healthcare Partners invests in companies located in the US. The firm targets companies operating in a broad range of sectors. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.1 - 7.5 million. It makes control investments and has a board seat requirements. | Analyste en capital-investissement | 29/02/2008 |
Thomas Weisel Asset Management LLC
 Thomas Weisel Asset Management LLC Investment ManagersFinance Thomas Weisel Asset Management (TWAM) offers US equity separately managed accounts in small-cap growth, small/mid-cap growth and mid-cap growth strategies. The firm's investment approach is based on the idea that investors inefficiently price growth stocks because they over-extrapolate near-term trends in company fundamentals. Their investment selection process is based on fundamental research and a systematic valuation discipline. TWAM seeks to actively manage risk/reward trade-offs across securities and sectors to provide a more efficient allocation of portfolio capital. Their strategies employ in-depth fundamental research and a bottom-up stock selection process to create optimized portfolios of US growth stocks. The firm's small-cap strategy is offered as a separately managed account and through commingled funds. The strategy focuses on investments in the stocks of small US companies with a market-cap of $50 million to $5 billion. The strategy is benchmarked against the Russell 2000 Growth Index. TWAM's small/mid-cap strategy is offered as a separately managed account. The strategy focuses on investments ion the stocks of US small and mid-sized companies with a market-cap of $50 million to $10 billion. The strategy is benchmarked against the Russell 2500 Growth Index. Their mid-cap strategy is offered as a separately managed account. The strategy focuses on investments in the stocks of US mid-sized companies with a market-cap of $1 billion to $25 billion. The strategy is benchmarked against the Russell Mid-Cap Growth Index. Though not limited by sector, TWAM tends to invest in the stocks of companies in the technology services, healthcare technology, electronic technology, industrial services and finance sectors. The firm maintains a high turnover rate. | Analyst-Equity | 31/12/2004 |
Formation de Michael J. Flaim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Thomas Weisel Asset Management LLC
Thomas Weisel Asset Management LLC Investment ManagersFinance Thomas Weisel Asset Management (TWAM) offers US equity separately managed accounts in small-cap growth, small/mid-cap growth and mid-cap growth strategies. The firm's investment approach is based on the idea that investors inefficiently price growth stocks because they over-extrapolate near-term trends in company fundamentals. Their investment selection process is based on fundamental research and a systematic valuation discipline. TWAM seeks to actively manage risk/reward trade-offs across securities and sectors to provide a more efficient allocation of portfolio capital. Their strategies employ in-depth fundamental research and a bottom-up stock selection process to create optimized portfolios of US growth stocks. The firm's small-cap strategy is offered as a separately managed account and through commingled funds. The strategy focuses on investments in the stocks of small US companies with a market-cap of $50 million to $5 billion. The strategy is benchmarked against the Russell 2000 Growth Index. TWAM's small/mid-cap strategy is offered as a separately managed account. The strategy focuses on investments ion the stocks of US small and mid-sized companies with a market-cap of $50 million to $10 billion. The strategy is benchmarked against the Russell 2500 Growth Index. Their mid-cap strategy is offered as a separately managed account. The strategy focuses on investments in the stocks of US mid-sized companies with a market-cap of $1 billion to $25 billion. The strategy is benchmarked against the Russell Mid-Cap Growth Index. Though not limited by sector, TWAM tends to invest in the stocks of companies in the technology services, healthcare technology, electronic technology, industrial services and finance sectors. The firm maintains a high turnover rate. | Finance |
CHL Healthcare Partners LLC
CHL Healthcare Partners LLC Investment ManagersFinance CHL Healthcare Partners invests in companies located in the US. The firm targets companies operating in a broad range of sectors. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.1 - 7.5 million. It makes control investments and has a board seat requirements. | Finance |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
